50mg Tigimax Tigecycline Injection

₹ 760/Piece

Strength50 mg
Pack Size1 Vial
BrandTigimax
Route Of AdministrationIV
IndicationComplicated Infection
Prescription TypePrescription

Tigimax 50mg Injection contains Tigecycline 50 mg, a broad-spectrum antibiotic used to treat various bacterial infections. As a glycylcycline antibiotic, Tigecycline works by inhibiting bacterial protein synthesis, thereby preventing bacteria from growing and reproducing. It is highly effective against multi-drug-resistant infections and is used in hospitalized patients for serious infections that require intravenous (IV) therapy.


 

Exports To: United States Of America | Canada | United Kingdom | Germany | Australia

Find products similar to 50mg Tigimax Tigecycline Injection

Find related categories

Shipping Information

AvailabilityIn Stock
PriceExcluding all taxes
Ships fromSurat
ShippingAs per delivery location

Product Image

50mg Tigimax Tigecycline Injection image 150mg Tigimax Tigecycline Injection image 250mg Tigimax Tigecycline Injection image 3

About the Company

GST Registration Year
2023
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Retailer
Number of Employees
Upto 10 People
Annual Turnover
0 - 40 L
IndiaMART Member Since
Dec 2018
GST
24**********1ZF
Import Export Code (IEC)
*******67C
Exports to
United States Of America | Canada | United Kingdom | Germany | Australia

Established in the year of 2022,We “Addik Pharma ExportWholesaler And Exporter of an extensive array of Pharmaceutical Tablet, Sildenafil Tablets, Anti Cancer Tablet, Eye Drop, Skin Care Medicine, Hair Care Medicine etc..  We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our Mr. Vijay Devrajbhai Bokha , whose continual backing and direction have been useful to us for attaining exponential development in the current market.